Genomic Companies in BioPortfolio's Corporate Database
Genomic company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Genomic companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Genomic Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Genomic Companies.
More Information about Genomic on BioPortfolio
We have published hundreds of Genomic news stories on BioPortfolio along with dozens of Genomic Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Genomic for you to read.
Showing "genomics genomic" Companies 1 to 25 of 499
Source BioScience LifeSciences
Source BioScience LifeSciences are European leaders in DNA sequencing, genomic services, bioinformatic analyses and offers a comprehensive portfolio of genomic reagents and antibodies. Source BioScience LifeSciences is your ideal outsourcing partner for all your sequencing requirements. We are your local Sanger sequencing provider operating facilities in London, Cambridge, Oxford, Nottingham,...
Foundation Medicine is dedicated to the development of comprehensive tests that will help physicians personalize cancer treatment for their patients. Foundation Medicineâs laboratory tests are designed to accommodate and assimilate a dynamic landscape of cancer genome and other molecular information and growing availability of treatment options. These...
LI-COR Biosciences is a leader in the design, manufacture, and marketing of integrated instrument systems for plant biology, biotechnology, drug discovery, and environmental research. LI-COR instruments for photosynthesis, carbon dioxide analysis, and light measurement are recognized world wide for standard-setting innovation in plant science research and environmental monitoring.The company pione...
InSite Vision is an ophthalmic products company currently focused on ocular infection, glaucoma, and retinal disease. The Company specializes in three platform technologies: topical drug delivery (DuraSite), genomics, and retinal drug delivery. As a result, the Company has a portfolio of both diagnostic and therapeutic products in early and late-stage development. The Company's lead product, AzaS...
Personalis provides researchers and clinicians accurate DNA sequencing and interpretation of human genomes. Our ACE (Accuracy and Content Enhanced) Technologyâ¢Â can supplement a standard exome or genome, substantially increasing its medically-relevant coverage and accuracy. Personalis builds on that with innovative algorithms and proprietary...
Personalized Medicine World Conference
Innovative genomic and proteomic technologies, new research findings, transformed business models, and the latest legislation initiatives and FDA policies will be the subject of the 2-day Personalized Medicine World Conferenceâ¢, PMWC 2011, in Mountain View on January 18-19, 2011. Co-hosted by Stanford Hospital & Clinics and produced by Silicom Venture...
The Multiple Myeloma Research Consortium
The Multiple Myeloma Research Consortium (MMRC) is a 509(a)3 non-profit organization that integrates leading academic institutions to accelerate drug development in multiple myeloma. It is led from MMRC offices in Norwalk, Conn., and comprises 16 member institutions: University of California, San Francisco, City of Hope, Dana-Farber Cancer Institute, Emory...
CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient. Strategically focused on coronary artery disease, cardiac arrhythmia and heart failure, CardioDx is poised to expand patient access and improve healthca...
SwitchGear Genomics Inc. is a leading provider of innovative products for studying gene regulation in the human genome. The company has developed a comprehensive approach to generate new insights into gene regulatory networks, allowing researchers to efficiently screen entire pathways in living cells. SwitchGear was founded in March 2005 by Dr. Richard Mye...
Partek Incorporated (www.partek.com) develops and globally markets quality software for life sciences research. Its flagship product, Partek® Genomics Suiteâ¢, provides innovative solutions for integrated genomics. Partek Genomics Suite is unique in supporting all major microarray and next generation sequencing platforms. Workflows offer streamlined...
Identigene, a Sorenson Genomics company, is the worldâs largest provider of direct-access DNA paternity testing. Founded in 1993, Identigene was the first DNA testing laboratory in the world to commercially use modern STR technology for paternity testing, and is the only company to sell a paternity test through major retail outlets. Identigene offers a full...
Mira Dx is a genomics company founded on research discovered at Yale University that is dedicated to the development and commercialization of novel microRNA-based tests for risk assessment and companion diagnostics. Our goal is to provide information that can help clinicians better understand cancer to better serve their patients, allowing earlier diagnosi...
Located in San Diego, California, Pathway Genomics owns and operates an onsite federally CLIA (Clinical Laboratory Improvement Amendments) certified and California state-licensed laboratory that offers genetic testing services. Using customized and scientifically validated genetic testing technologies within a controlled and secure environment, Pathway Gen...
AutoGenomics, Inc. and PGXL Labs
AutoGenomics Inc., a privately held company based in Vista, CA, has developed the first automated, microarray-based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their l...
Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the growing understanding of the molecular blueprint of cancer. Using its powerful Insights-to-Validation⢠Platform and proprietary chemical library, Blueprint Medicines is working to develop new therapeutic compounds and combination therapie...
Evozym Biologics, Inc., is an evolutionary and environmental biology company revolutionizing statistical genomics to exploit new potentials for bioengineered protein design, bioremediation and drug-targeting. Two professors, Joseph J. Grzymski and Adam G. Marsh, with more than 25 years research experience, founded the company. Evozymâs proprietary pla...
DxTerity Diagnostics (www.dxterity.com) is an emerging genomics company that has developed a revolutionary medical device that allows technicians to run complex genomic tests in one hour in the doctorâs office. DxTerityâs core technology platform is known as NEATTM or Non-Enzymatic Amplification Technology. NEATTM based Solutions enable the low-c...
PathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The companyâs approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from comp...
Medicinal Genomics is the first known organization to sequence the complete genomes of Cannabis sativa and Cannabis indica. Aside from being a useful tool to discover small molecule therapeutic drug candidates, there are many other commercial applications of these sequences, including the design of genomic assays that measure genes predictive of Cannabinoi...
Aestus Therapeutics and Prosidion Ltd.
Aestus Therapeutics, Inc. is a translational medicine company focused on serious neurological diseases. Capitalizing on genomic data analysis to discover novel links between these diseases and well-studied biological pathways, Aestus identifies drug candidates in clinical Phase I or later. By developing these drugs in novel disease areas such as chronic pa...
Conditas Biotechnology Group, LLC
Conditas Biotechnology Group, LLC is a boutique firm representing on- and off-shore Contract Research Organizations (CROs) and service providers in the biotechnology and pharmaceutical industry to their current and potential future customers from academia, biotech, and pharma. Based in Brookline, Massachusetts, their client CROs include experts in all...
Cofactor Genomics is a privately held biotechnology company that employs experimental design, next-generation sequencing, and proprietary analysis technology and pipelines to drive the discovery and design of new products and processes for the life sciences field. Cofactorâs D&A (Design & Analysis) Solution is constructed to specifically assist those...
Founded by Professor Ed Southern, Oxford Gene Technology (OGT) provides innovative clinical genetics and diagnostic solutions to advance molecular medicine. The company has two trading businesses, Biomarker Discovery and Clinical & Genomic Solutions. Biomarker Discovery: OGT delivers tailored biomarker discovery solutions that optimise drug and diagnostic...
Cancer Commons is a nonâprofit open science initiative dedicated to improving outcomes for todayâs cancer patients. Our goals are to: 1) give each patient the best possible outcome by individualizing their treatment based on their tumorâs genomic subtype; 2) learn as much as possible from each patientâs response, and 3) rapidly disseminate wha...
Natural Molecular Testing Corporation
Natural Molecular Testing Corporation (NMTC) is a privately-owned, high-complexity molecular testing facility. NMTC provides genetic testing services and resources for our clinical partners to assist them in better caring for their patients by advancing patient care through the latest breakthroughs in genomic technology.
